Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium

被引:30
作者
Loewen, N
Leske, DA
Chen, Y
Teo, WL
Saenz, DT
Peretz, M
Holmes, JM
Poeschla, EM
机构
[1] Mayo Clin, Program Mol Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Med, Rochester, MN 55905 USA
关键词
feline immunodeficiency virus; lentiviral vector; integrase mutant; retina; gene therapy;
D O I
10.1002/jgm.447
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background In neonatal and adult rodent retina, substantial lentiviral vector expression has been detected primarily in retinal pigment epithelium (RPE), except in very young animals (2-5 days post-natal). In non-retinal tissues, studies of lentiviral vectors have utilized various controls. Among the most stringent are class I integrase mutants, which selectively block the integration reaction while leaving all other gag/pol-encoded functions intact. For HIV-1 vectors injected into brain, these have been used to simultaneously control for pseudotransduction and verify that long-term expression requires integration. Such experiments compare particles that differ only in a single amino acid within a single enzyme that forms a very small molar fraction of the virion. Class I integrase mutants have not been described for feline immunodeficiency virus (FIV) integrase, or tested in the eye for any lentiviral vector. Methods We compared subretinally and intravitreally injected FIV vectors and followed animals for up to 7 months, a duration that exceeds prior studies. We also compared the wild-type (WT) vector with one incorporating a single class I amino acid mutation in FIV integrase (D66V). A mock vector (packaging construct absent) was an alternative control. All vectors were vesicular stomatitis virus glycoprotein G (VSV-G)-pseudotyped and were injected on day 7 of life. One group of animals received either subretinal or intravitreal injections of WT vector in the right eyes. Control left eyes were injected with mock vector. These animals were sacrificed at 2 or 7 days post-injection. A second group received subretinal injections of either WT vector or equivalent D66V vector (reverse transcriptase-normalized to WT), and were analyzed after 2, 3 and 7 months. All eyes were scored for marker gene (beta-galactosidase) expression by an observer blinded to vector assignments. Results Subretinal FIV vector injections were much more effective than intravitreal injections. The RPE was the principal retinal layer transduced by the WT vector, and at least 50% of the area of the retina expressed the marker gene at 3 and 7 months. Occasional cells in inner retinal layers also expressed beta-galactosidase at these time points. The sustained retinal expression produced by subretinally injected vector was blocked by the D66V mutation. Conclusions These results show that class I integrase mutant FIV vectors are useful control vectors, and that VSV-G-pseudotyped FIV vectors produced extensive retinal expression for at least 215 days, the longest duration yet reported for lentiviral vectors in retina. Transgene expression is mostly restricted to RPE after post-natal day 7 in rats, suggesting that FIV vectors could be used to target RPE for gene therapy. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:1009 / 1017
页数:9
相关论文
共 49 条
  • [1] Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model
    Auricchio, A
    Kobinger, G
    Anand, V
    Hildinger, M
    O'Connor, E
    Maguire, AM
    Wilson, JM
    Bennett, J
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (26) : 3075 - 3081
  • [2] In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium
    Bainbridge, JWB
    Stephens, C
    Parsley, K
    Demaison, C
    Halfyard, A
    Thrasher, AJ
    Ali, RR
    [J]. GENE THERAPY, 2001, 8 (21) : 1665 - 1668
  • [3] Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus
    Berkowitz, R
    Ilves, H
    Lin, WY
    Eckert, K
    Coward, A
    Tamaki, S
    Veres, G
    Plavec, I
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (07) : 3371 - 3382
  • [4] Blomer U, 1997, J VIROL, V71, P6641
  • [5] VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS
    BURNS, JC
    FRIEDMANN, T
    DRIEVER, W
    BURRASCANO, M
    YEE, JK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 8033 - 8037
  • [6] DOMAINS OF THE INTEGRASE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESPONSIBLE FOR POLYNUCLEOTIDYL TRANSFER AND ZINC-BINDING
    BUSHMAN, FD
    ENGELMAN, A
    PALMER, I
    WINGFIELD, P
    CRAIGIE, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3428 - 3432
  • [7] ROUS-SARCOMA VIRUS INTEGRASE PROTEIN - MAPPING FUNCTIONS FOR CATALYSIS AND SUBSTRATE-BINDING
    BUSHMAN, FD
    WANG, BB
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (04) : 2215 - 2223
  • [8] ROLE OF MEMBRANE PHOSPHOLIPIDS AND GLYCOLIPIDS IN CELL-TO-CELL FUSION BY VSV
    CONTI, C
    MASTROMARINO, P
    ORSI, N
    [J]. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 1991, 14 (04) : 303 - &
  • [9] Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors
    Curran, MA
    Kaiser, SM
    Achacoso, PL
    Nolan, GP
    [J]. MOLECULAR THERAPY, 2000, 1 (01) : 31 - 38
  • [10] Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
    Dawson, DW
    Volpert, OV
    Gillis, P
    Crawford, SE
    Xu, HJ
    Benedict, W
    Bouck, NP
    [J]. SCIENCE, 1999, 285 (5425) : 245 - 248